Medication info
Newcozartan Tablets 10/50 mg (Amlodipine, Losartan Potassium)

Newcozartan Tablets 10/50 mg (Amlodipine, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›13.888mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Dasan Pharmaceutical Co., Ltd.
Appearance
Pale pink rectangular film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201903730 · Approved 2019.06.04

Summary

Main use
Treatment of essential hypertension and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take the medicine at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may be switched to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to treat should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination product compared with monotherapy. The usual dose is 5/50 milligrams once daily; if blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dosage adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Elderly patients: In patients 75 years of age or older, an initial dose of losartan of 25 milligrams once daily is recommended; therefore, use of this medicine as initial treatment is not recommended.
Child dose
○ Children: Use of this medicine is not recommended because its safety and efficacy have not been established in pediatric patients 18 years of age or younger.

Ingredients

Manufacturer
Dasan Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or losartan. It is also applied as an initial therapy for patients with stage 2 hypertension who require combination therapy to reach their target blood pressure. In other words, this drug is used to effectively improve hypertension through proper blood pressure management.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take the medicine at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may be switched to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to treat should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination product compared with monotherapy. The usual dose is 5/50 milligrams once daily; if blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dosage adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Elderly patients: In patients 75 years of age or older, an initial dose of losartan of 25 milligrams once daily is recommended; therefore, use of this medicine as initial treatment is not recommended.

Child dose

○ Children: Use of this medicine is not recommended because its safety and efficacy have not been established in pediatric patients 18 years of age or younger.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the 2nd and 3rd trimesters, so it should be discontinued immediately upon confirmation of pregnancy. It may lower blood pressure rapidly, so patients with low blood volume or those on diuretics should manage their condition well before starting this medication. Patients who are allergic to the active ingredients, have severe liver dysfunction, are pregnant or breastfeeding, have severe aortic stenosis, or are in shock should not be administered this medication. Patients with high potassium levels or poor kidney function, as well as those requiring strict sodium restriction, should use this medication with caution. Side effects such as dizziness, headaches, indigestion, edema, or skin rashes may occur during use; if symptoms persist, consult a physician. Due to the blood pressure-lowering effect of this medication, caution is necessary when driving or operating dangerous machinery. Patients with impaired liver or kidney function may require dose adjustment and should undergo regular examinations. Drug interactions may occur if taken with other antihypertensives or potassium supplements, so it is essential to inform healthcare providers about all medications being taken. Pregnant or breastfeeding women should refrain from using this medication, and its use is not recommended for children or elderly individuals aged 75 or older. In case of overdose, severe hypotension or cardiac problems may arise, so the dosage should be strictly adhered to, and immediate medical attention should be sought if abnormal symptoms occur. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

  • Dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pit edema
Show 160 more
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux
  • constipation
  • itching
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • dizziness (vertigo)
  • conjunctival injection
  • increased urination
  • fatigue
  • edema
  • vasculitis
  • tension increase
  • sensory decrease
  • abnormal sensations
  • peripheral neuropathy
  • syncope
  • taste disturbances
  • tremors
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary dysfunction
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • hypotension
  • sinus block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • skin erythema
  • maculopapular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • diarrhea
  • sinus dysfunction
  • pharyngitis
  • myalgia
  • insomnia
  • bloating
  • abdominal pain
  • angioedema
  • palm skin peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • hypotension
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • dental pain
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory decline
  • decreased libido
  • memory impairment
  • migraine
  • neuro-excitability
  • panic disorder
  • sleep disorders
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • pulmonary congestion
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • rash
  • perspiration
  • urticaria
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision decline
  • urethral infection
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome
  • elevated serum creatinine
  • elevated liver enzymes
  • hypotension
  • loss of consciousness
  • shock symptoms
  • hypotension
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the medication's effect for a longer period.

Appearance and packaging

Appearance

Pale pink rectangular film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.